Antihypertensives and skin cancer: Evidence from the FDA Adverse Event Reporting System

J Am Acad Dermatol. 2026 Jun;94(6):1771-1774. doi: 10.1016/j.jaad.2026.01.070. Epub 2026 Feb 3.
No abstract available

Keywords: FAERS; antihypertensive agents; melanoma; nonmelanoma skin cancer; pharmacovigilance.